SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): APRIL 11, 2002
--------------
INVERNESS MEDICAL INNOVATIONS, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 001-16789 04-3565120
--------------------------------------------------------------------------------
(State or other jurisdiction) (Commission (IRS Employer
of incorporation) File Number) Identification No.)
51 SAWYER ROAD, SUITE 200, WALTHAM, MA 02453
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (781) 647-3900
----------------------------
NOT APPLICABLE
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5--OTHER EVENTS.
On April 2, 2002, Inverness Medical Innovations, Inc. (the "Company")
filed a Registration Statement on Form S-8 (file number 333-85402) with the
Securities and Exchange Commission (the "Registration Statement"). Attached as
Exhibit 23.1 to this Current Report on Form 8-K is a consent of Arthur Andersen
LLP to incorporate by reference in the Registration Statement its report dated
March 1, 2002 included in the Company's Form 8-K/A filed with the Securities and
Exchange Commission on March 5, 2002.
ITEM 7--FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
Exhibit No. Description
23.1 Consent of Arthur Andersen LLP.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INVERNESS MEDICAL INNOVATIONS, INC.
/s/ Duane L. James
-----------------------------------------
Duane L. James, Vice President of Finance
and Treasurer
Date: April 11, 2002
-2-
EXHIBIT INDEX
Exhibit No. Description
23.1 Consent of Arthur Andersen LLP.
-3-